financetom
Business
financetom
/
Business
/
US Supreme Court tosses ruling faulting FDA for denying flavored vape products
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Supreme Court tosses ruling faulting FDA for denying flavored vape products
Apr 2, 2025 7:47 AM

WASHINGTON (Reuters) -The U.S. Supreme Court threw out on Wednesday a judicial decision that found the U.S. Food and Drug Administration acted unlawfully in refusing to let two e-cigarette companies sell flavored vape products that regulators consider a health risk to youths.

The justices in a unanimous ruling threw out a lower court's ruling that the FDA had failed to follow proper legal procedures under a federal law called the Administrative Procedure Act when it rejected the applications by the companies, Triton Distribution and Vapetasia, to sell these nicotine-containing products.

An FDA rule that took effect in 2016 under Democratic President Barack Obama deemed e-cigarettes to be tobacco products that, like traditional cigarettes, are subject to agency review under a 2009 federal law called the Tobacco Control Act. The law requires manufacturers of e-cigarette products to apply for authorization to sell nicotine vaping devices and e-liquids.

Triton Distribution and Vapetasia filed FDA applications in 2020 for products with flavors such as sour grape, pink lemonade and crème brulee, and names including "Jimmy The Juice Man Peachy Strawberry" and "Suicide Bunny Mother's Milk and Cookies" - offerings that critics have said were designed to appeal to minors. The FDA denied the Triton and Vapetasia applications as well as hundreds of others by various companies involving more than a million flavored vape products.

During arguments in the case, a Justice Department lawyer arguing for the FDA said the companies knew throughout the application process that the agency was concerned about the fact that flavors are attractive to youth and about the addictive nature of nicotine, a chemical dangerous to developing brains.

In order to win regulatory approval, e-cigarette companies must demonstrate that a product would be "appropriate for the protection of the public health." That means that any health benefits - such as helping traditional cigarette smokers transition to generally less-harmful vaping - must outweigh the risks of bringing the new product to market.

The e-cigarette companies argued that the FDA improperly assessed their applications under a regulatory standard that differed from published guidance they had relied upon.

The FDA found that in 2020 nearly one in five high school students and almost one in 20 middle school students used e-cigarettes, making e-cigarettes "the most widely used tobacco product among youth by far."

The agency over the years has approved only 34 flavored e-cigarette varieties, all tobacco or menthol flavored. It maintains that it has not categorically banned flavored e-cigarette products. But companies seeking its approval to sell these products face an especially tough health benefits-versus-risk legal test as a result of the FDA's finding that flavored e-cigarettes pose a "known and substantial risk" to youth.

Triton and Vapetasia in 2021 asked the New Orleans-based 5th U.S. Circuit Court of Appeals to review the FDA's denial of their applications. The full slate of 5th Circuit judges ruled 10-6 that the FDA had been arbitrary and capricious, in violation of a federal law called the Administrative Procedure Act, by denying the applications without considering plans by the companies to prevent underage access and use.

Seven other federal appellate courts had sided with the FDA in similar cases.

The Supreme Court on Nov. 25 also declined to hear an appeal by RJ Reynolds and other tobacco companies of a lower court's ruling upholding graphic health warnings required by the FDA on cigarette packs.

The Supreme Court, with a 6-3 conservative majority, has reined in the authority of federal agencies in a series of cases in recent years. In another high-profile case involving the FDA, the Supreme Court in June decided on procedural grounds to reject a bid by anti-abortion groups and doctors to restrict access to the abortion pill mifepristone.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Brazilian soy shipments to China from 5 firms suspended on phytosanitary grounds, sources say
Exclusive-Brazilian soy shipments to China from 5 firms suspended on phytosanitary grounds, sources say
Jan 22, 2025
BEIJING (Reuters) - China, the world's biggest soybean buyer, has stopped receiving Brazilian soybean shipments from five entities after cargoes did not meet phytosanitary requirements, two sources with direct knowledge of the matter told Reuters on Wednesday. Brazil, the world's biggest exporter of the oilseeds, has from Jan. 8 suspended shipments to China from Terra Roxa Comercio de Cereais, Olam...
J&J beats quarterly sales and profit estimates on cancer drug sales
J&J beats quarterly sales and profit estimates on cancer drug sales
Jan 22, 2025
(Reuters) - Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales and profit above Wall Street estimates on Wednesday, driven by strong sales of its cancer treatments. The New Jersey-based drugmaker also said it expects 2025 sales of between $90.9 billion and $91.7 billion and to earn between $10.75 and $10.95 per...
Commerce Bancshares Q4 Earnings, Revenue Rise
Commerce Bancshares Q4 Earnings, Revenue Rise
Jan 22, 2025
06:23 AM EST, 01/22/2025 (MT Newswires) -- Commerce Bancshares ( CBSH ) reported Q4 earnings Wednesday of $1.01 per share, up from $0.79 a year earlier. Analysts polled by FactSet expected $0.93. Total revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and non-interest income, was $422.1 million, compared with $393.3 million a year...
Prince Harry's lawyer: Settlement of lawsuit is 'monumental victory'
Prince Harry's lawyer: Settlement of lawsuit is 'monumental victory'
Jan 22, 2025
LONDON, Jan 22 (Reuters) - Prince Harry's lawyer David Sherborne said on Wednesday the settlement of the lawsuit against Rupert Murdoch's News Group Newspapers (NGN) was a monumental victory that represents what he described as a vindication. Outside court, Sherborne said that after endless denials by NGN the group has been held to account but that many of those behind...
Copyright 2023-2026 - www.financetom.com All Rights Reserved